Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06763952 · ClinicalTrials.gov registry record · NA
Leveraging Artificial Intelligence to Prevent Vision Loss From Diabetes
A NA study, sponsored by University of Wisconsin, Madison.
- Not yet
- Registry status
- NA
- Development phase
- 4,000
- Enrollment target
NCT06763952: Clinical Trial NA study, sponsored by University of Wisconsin, Madison.
NCT06763952 is a NA study that has not yet begun recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 4,000 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (185% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06763952, a NA study, has not yet begun recruiting, sponsored by University of Wisconsin, Madison.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 4,000 participants
- Enrollment target
Study Summary
This study aims to investigate whether a novel artificial intelligence based screening strategy (AI-Based point of caRe, Incorporating Diagnosis, SchedulinG, and Education or AI-BRIDGE), which allows primary care providers to screen patients for vision-threatening diabetic eye disease in the primary care clinic, improves screening and follow-up care rates across race/ethnicity groups and reduces racial/ethnic disparities in screening.
Primary Outcome
Proportion of patients who follow-up with recommended eye care in the AI-BRIDGE and usual-care arms within 6 months of the recommendation.
Interventions
- OTHER AI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2030-05 |
| Phase | NA |
What is known before NCT06763952 opens enrollment
NCT06763952 is an interventional study that assigns participants to a tested intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (185% higher).
The record links to 0 conditions, and to 1 intervention - of which AI is the first listed.
NCT06763952 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06763952 about?
NCT06763952 is a clinical study titled "Leveraging Artificial Intelligence to Prevent Vision Loss From Diabetes". This study aims to investigate whether a novel artificial intelligence based screening strategy (AI-Based point of caRe, Incorporating Diagnosis, SchedulinG, and Education or AI-BRIDGE), which allows primary care providers to screen patients for vision-threatening diabetic eye disease in the primary...
What is the current status of trial NCT06763952?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 4,000 participants. The study started on 2026-08-01. Estimated completion is 2030-05.
What interventions are being tested in trial NCT06763952?
The interventions under investigation include: AI (OTHER).
Who is sponsoring clinical trial NCT06763952?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06763952's enrollment target sits among peer trials
4,000 32nd of 2000 higher than 1,965 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI